MedTrace Logo

Efficacy and Safety of VVZ-149 Injections in Patients Undergoing Laparoscopic Colectomy

NCT05764525 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 285

Last updated 2025-02-20

Study results available
· View outcomes & findings →

Summary

The purpose of this phase 3 study is to evaluate the efficacy and safety of VVZ-149 Injections for the treatment of postoperative pain following laparoscopic colectomy.

Conditions

  • Pain, Postoperative
  • Acute Pain

Interventions

DRUG

VVZ-149 Injections

IV infusion of 1000 mg of VVZ-149

DRUG

Placebo

IV infusion of 0 mg of VVZ-149

Sponsors & Collaborators

  • Vivozon Pharmaceutical Inc.

    lead INDUSTRY

Principal Investigators

  • Doo Lee, PhD · Vivozon Pharmaceutical Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-19
Primary Completion
2022-11-03
Completion
2022-11-22
FDA Drug
Yes

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05764525 on ClinicalTrials.gov